reSee.it - Related Video Feed

They classified the post-vaccine troubles into three categories: immediate effects like pain, swelling, and redness; symptoms resembling COVID-19; and post-COVID injection syndromes. The latter includes inflammatory and multisystemic syndromes with various complications such as cardiac, neurological, hematological, vascular, immune system, reproductive health, cancer, and congenital issues. It is important to consult a doctor if experiencing any of these symptoms.

The discussion centers on a cruise-ship hantavirus outbreak and how to interpret its significance without panicking. The speakers question what is actually known about hantavirus testing, the specific strains involved, and how reliable the tests are compared to COVID-19 PCR testing. They note hantavirus is an RNA virus and discuss the possibility of ivermectin as a therapeutic, while raising concerns about government secrecy and information control. Key points raised: - Hantavirus tests and strain identification: The panel asks how testing is done, whether tests distinguish the Andes virus involved on the ship, and how reliable the tests are. They point out that hantavirus is a rare infection in the United States and that historically the CDC used antibodies, while PCR is widely available but must be interpreted in the proper clinical context. - Transmission and mortality: It is stated that hantaviruses are not known to spread between humans, and the Andes virus is the exception with rare human-to-human transmission requiring very close contact. The speakers reference reported mortality rates for hantavirus (between 25% and 50%), and question how many people on the cruise may be affected given three deaths. - Vaccine and bioweapons concerns: There is skepticism about why a vaccine would be developed for a virus that is not readily transmissible between humans, with speculation about doomsday scenarios and potential bioweapons research. Moderna is mentioned as having announced vaccine work in 2024, and there is discussion about the stock decline related to COVID-19 vaccine uptake. - Ivermectin and treatment debates: The conversation revisits ivermectin as a potential antiviral for RNA viruses like hantavirus, noting patterns from the COVID-19 era of suppression of certain treatments and questioning the standards of evidence used to promote or censor therapies. A prior book, The War on Ivermectin, is referenced in relation to disinformation about the drug. - Media dynamics and public perception: The dialogue highlights concerns about how media coverage and social media influence public fear, including mentions of influencers and a pattern of rapid information spread. They discuss the possibility that the outbreak’s prominence could be driven by media or other non-pandemic factors, paralleling past COVID coverage. - Adverse-event chatter: There is mention of hantavirus appearing among listed possible adverse events for a COVID-19 vaccine, with questions about why such a link would be considered and the strength of that association. A colleague notes a surge of hantavirus literature around the outbreak, which they find unusual for a limited outbreak. - Long COVID and brain effects (aside from the outbreak): A NYU Langone Health study is cited, reporting that long COVID sufferers show changes in a brain region involved in cleaning brain tissue, linking chronic inflammation and spike protein exposure to potential early signs of Alzheimer’s disease, as part of a broader discussion on lingering effects of viral illnesses. Overall, the speakers emphasize asking cautious, clinically grounded questions about the outbreak, testing, transmission risk, and the broader media and political context, while warning against fearmongering and noting the possibility that the intense coverage may reflect patterns observed during the pandemic.

Some research suggests the coronavirus can infect brain cells, impacting memory and cognitive functions. Understanding this could help treat long COVID symptoms like brain fog and fatigue. Early treatment may prevent brain damage.

Yale experts have identified post-vaccination syndrome (PVS) linked to mRNA COVID vaccines, causing brain fog, dizziness, tinnitus, and exercise intolerance. Sufferers show immune cell changes and coronavirus proteins even without having had COVID. The condition may reactivate the Epstein Barr virus. PVS patients had higher COVID spike protein levels than long COVID patients. This may be due to the shots' genetic material integrating with human genes, constantly activating protein production, raising safety concerns. Some believe the censorship of early vaccine side effect stories was brutal. There's a correlation between vaccine rates and unexplained deaths, but more research is needed to fully understand these mechanisms. To keep Infowars going, check out survival shield x2, brain force ultra, body's ultimate formula, vitamin C with zinc, vaso beets, ultra twelve, pain MD, The Great Awakening book, and Infowars gold collectible art card at infowarsstore.com.

The largest COVID study found a link between the vaccine and heart/brain disorders. Data from 100 million people in 8 countries showed slight increases in conditions like myocarditis and Guillain Barre syndrome. The study does not prove the vaccine caused these issues. Despite concerns, experts say the vaccine's benefits outweigh the risks. People like Elizabeth Foster question the vaccine's impact on their health. It's important to consult with a doctor before deciding to get vaccinated.

Having COVID may lead to a slight decline in cognitive function, with a 3-point IQ loss for those who recovered within 12 weeks and a 9-point loss for ICU patients. Long COVID patients experience more significant deficits. The study suggests these effects may improve over time. Doctor Adam Hampshire finds the findings promising, especially for those with persistent symptoms. Joanna, who has long COVID, highlights the need for better support and access to clinics for those affected. More research and funding are essential for effective care and management.

To help cleanse the body of spike proteins from both the virus and the vaccine, a combination of nattokinase (2,000 to 4,000 units twice daily), bromelain (500 to 1,000 milligrams once daily), and curcumin (500 to 1,000 milligrams daily) is recommended. The spike protein, an engineered protein, may remain in the body for a long time and can lead to autoimmune responses, where the body attacks itself. Long COVID symptoms are attributed to the presence of this spike protein, which can persist after infection and is more abundant following vaccination. Antibodies against the spike protein can be measured, indicating its lingering presence in the body.

The hardest part of being COVID aware is watching people unknowingly get infected and risk long COVID. The virus weakens the immune system, making people susceptible to other illnesses. Many are unaware of the risks and continue as if it's 2019. The lack of measures and education contributes to the spread. Long COVID can cause brain damage and heart issues. It's concerning to see so many unaware of the dangers they face.

Vaccinated individuals may still get COVID, but are less likely to experience severe effects like ICU admission or death. Vaccines were introduced late in the pandemic, after the virus had become milder and treatment had improved. Studies show misclassification bias in reporting vaccinated vs. unvaccinated hospitalizations. Some reports indicate higher rates of hospitalization and death among the vaccinated. Risk of COVID increases with each vaccine dose. Post-vaccine deaths are concerning.

Long COVID, caused by the spike protein, is affecting multiple medical disciplines. Since 2022, I've seen over 2,000 patients with COVID-19 or vaccine-related issues. Many patients had faith in medicine shattered due to adverse effects. Some were forced to choose between vaccination or losing their careers. Military service members are being harmed, with 30 individuals in my clinic facing significant issues like myocarditis and being medically discharged.

A study from the Oxford Academic QJM Medical Journal suggests a potential association between COVID-19 vaccination and the development of Alzheimer's disease. The study, conducted in Seoul, South Korea, analyzed data from a random 50% sample of city residents aged 65 and above. Findings showed an increased incidence of mild cognitive impairment (MCI) and Alzheimer's disease (AD) in vaccinated individuals, particularly those receiving mRNA vaccines within 3 months post-vaccination. No significant relationship was found with vascular dementia or Parkinson's disease. Preliminary evidence suggests a potential link between COVID-19 vaccination, particularly mRNA vaccines, and increased incidences of AD and MCI. The study underscores the need for further research to elucidate the relationship between vaccine-induced immune responses and neurodegenerative processes, advocating for continuous monitoring and investigation into vaccines' long-term neurological effects. The CDC and FDA still recommend COVID-19 vaccines.

A Yale-led study has found disturbing immune system changes in individuals experiencing chronic symptoms post-COVID-19 injection, referred to as post-vaccination syndrome (PVS). The research, involving multiple institutions, identified immunological alterations in PVS patients, including altered T cell populations, lower anti-spike IgG titers, Epstein-Barr virus reactivation, and persistent circulating spike protein. These findings mirror observations in long COVID studies. The study suggests that persistent antigenemia could drive chronic inflammation and prolonged immune activation. Reactivation of the Epstein-Barr virus and elevated autoantibody levels raise concerns about potential autoimmune responses. Researchers emphasize the urgent need for further investigation into these rare but persistent immune-related adverse events to refine vaccine strategies and ensure the safety of all populations.

The comparison to HIV is important because, like early HIV infections, mild or moderate COVID can cause unseen destruction. With HIV, people were infected for years before symptoms appeared, while the virus quietly destroyed the immune system. However, the HIV epidemic spurred brilliant science that changed how HIV is treated. We are now learning about mitochondria, viral impact, brain fog, changes in neurons, and cells that nourish neurons because of Long COVID. The goal is to reach a point where, through research, people with Long COVID can not only survive but thrive, just as HIV patients can live normal lifespans today.

In the question, myocarditis is discussed in relation to COVID-19. It has been mentioned for some time that infection with the novel coronavirus can lead to myocarditis, and that in some cases myocarditis can be severe or progress to myocarditis with structural complications. It is noted that myocarditis can also occur after vaccination, but the incidence is small and the symptoms are mild, with most people recovering. The speaker emphasizes that even when myocarditis occurs after vaccination, the risk is small and the condition tends to be mild. The statement asserts that almost all individuals recover from vaccine-associated myocarditis. Therefore, even if people who have received a vaccine develop myocarditis, the situation is not something to be alarmed about. The speaker argues that the benefits of vaccination far outweigh the risks, and that the idea of significant changes or issues related to the vaccine is not supported. The overall conclusion presented is that the risks of myocarditis, whether from infection or vaccination, are outweighed by the benefits of vaccination. Key points reiterated include: - COVID-19 infection can cause myocarditis, sometimes with considerable severity or with structural heart complications. - Myocarditis can also occur after vaccination, but the occurrence is rare and the symptoms are generally mild. - The vast majority of people with vaccine-associated myocarditis recover. - The perceived risk of myocarditis following vaccination should not be a cause for alarm, given that the benefits of vaccination are greater. - There is no indication that anything about the vaccine itself changes in a way that would alter this risk-benefit balance. Overall, the message is that myocarditis is a potential outcome associated with both infection and vaccination, but the frequency is low, the illness is typically mild, recovery is common, and vaccination remains advantageous.

Comparison to HIV is important as both were asymptomatic initially. HIV taught us about immunology and revolutionized cancer therapy. Long COVID is shedding light on mitochondria, viral impact, brain fog, and neuron changes. Despite the unseen damage of mild/moderate COVID, like HIV, it can lead to scientific breakthroughs. Research on long COVID is crucial for people to not just survive but thrive.

Some individuals are experiencing health issues that resemble long COVID, but are actually due to mRNA vaccines. These can include cognitive dysfunction, such as severe word recall problems, and a condition where patients feel suffocated despite normal heart and lung function. This is linked to issues with blood returning to the heart. Autonomic dysfunction is also noted, with some patients unable to sit up without severe symptoms. While these conditions can be serious, they are often reversible over time, potentially driven by residual spike protein from the vaccines. The mRNA vaccines turn the body into a spike protein factory, which raises concerns about their safety. An alternative, the Novavax protein vaccine, provides a controlled amount of spike protein without these risks and should be considered more critically.

Inflammation in the brain from COVID can lead to long-term cognitive issues. The high levels of inflammation seen in even mild cases of COVID worried me about a potential neurological crisis. The rates of lasting cognitive symptoms in COVID survivors are concerning. Effective therapy is crucial to help the millions who may suffer from these symptoms.

Having COVID may lead to a small cognitive decline, with a 3 point IQ loss for those recovering within 12 weeks, and a 9 point loss for ICU patients. Long COVID can cause brain fog, fatigue, and heart issues. The study shows improvements over time for some. More support is needed for long COVID patients, including better access to clinics and research funding for treatments.

They classified the post-vaccine troubles into three categories: immediate effects like pain, swelling, and redness; symptoms resembling COVID-19; and post-COVID injection syndromes. The latter includes inflammatory and multisystemic syndromes with various complications such as cardiac, neurological, hematological, vascular, immune system, reproductive health, cancer, and congenital issues. It is important to consult a doctor if experiencing any of these symptoms.

Residual effects from one or two COVID shots can include late blood clots and cardiac arrests years later. The mRNA and spike protein from the shots can linger in the body, causing various health issues like heart and brain damage, blood clots, and immunologic problems. A spike detox program is recommended to address these concerns.

The comparison to HIV is important because both viruses can be asymptomatic. HIV taught us a lot about immunology and changed cancer therapy. Similarly, we are now learning about the impact of the virus on mitochondria, brain fog, and our neurons through long COVID. Mild and moderate COVID can cause destruction, just like HIV did to our immune system. However, the brilliant science that came out of HIV research transformed how we treat the virus, allowing people to live normal lives. We need to do the same for long COVID, so that those affected can not only survive but also thrive.

A new Yale Medical School study reveals that individuals experiencing long COVID may actually be suffering from mRNA vaccine injuries, specifically vaccine-induced AIDS (VAIDs). The study, led by Bornalli Botticelli, indicates that mRNA injections alter human biology, leading to long-term spike protein production that increases over time. Scientists warn that these vaccines change T-cell immunophenotypes, triggering VAIDs. We were forced to take these experimental vaccines or risk losing our jobs, and we were lied to about their safety and efficacy. The vaccines didn't prevent contraction or transmission of the virus, and they caused heart issues, blood clots, and autoimmune disorders. Now, we're finding out that the mRNA jab causes VAIDs in many people, marking one of the most egregious scandals in American history.

The mRNA COVID-19 vaccine delivers instructions for creating spike proteins, which then triggers an immune response. The vaccine and spike protein are said to break down and disappear within days, leaving no trace and not affecting DNA. The vaccine is taken up at the injection site and quickly metabolized. However, an Australian Therapeutic Goods Administration document indicates the vaccine distributes throughout the body, including adipose tissue, adrenal glands, and the brain. There was allegedly no data on how quickly the mRNA degrades. Research indicates vaccine mRNA can be detected up to 14-15 days post-vaccination in some individuals. A rare post-vaccination syndrome (PVS) is associated with chronic conditions and elevated spike protein levels up to 709 days post-vaccination, even without detectable SARS-CoV-2 infection. One hypothesis suggests that the mRNA may reverse transcribe and integrate into DNA, causing continuous spike protein production and potentially leading to T cell exhaustion. The possibility of germline transfer and long-term health consequences is raised.

People around the world are reporting increased intolerance, impatience, and slower thinking. Some struggle with simple equations. There is a need for more studies to understand this phenomenon. Certain neurologic syndromes have been linked to vaccines, such as viral reactivation. Examples include a former US Senator who had lethal neuroinvasive varicella zoster reactivation, a pop singer with Ramsay Hunt syndrome affecting his facial nerve, and a man in Greece who developed an invasive basilar cancer in the temporal area after receiving the COVID-19 vaccine. These cases are well-documented and published in peer-reviewed literature. It is the first known case of COVID-19 vaccine-induced fatal cancer with a neuroinvasive syndrome.

The comparison to HIV is important because both HIV and long COVID can be asymptomatic for a long time before symptoms appear. HIV taught us a lot about immunology and revolutionized cancer therapy. Similarly, long COVID is teaching us about the impact of mitochondria and viruses on our brain function. Just like HIV destroyed our immune system, mild and moderate cases of COVID can cause unseen damage. However, the knowledge gained from studying HIV led to significant advancements in treatment, allowing people to live normal lives. We need to conduct research to ensure that people with long COVID can not only survive but also thrive.